Company Celltrion, Inc.

Equities

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 2024-12-09			5-day change	1st Jan Change
175,100.00 ^KRW	-2.78%		-5.15%	-13.10%

04:18am	Health Canada Approves Celltrion's Asthma Biosimilar Omlyclo; Shares Rise 3%	MT
03:09am	Celltrion Begins Commercial Operation of Third Domestic Manufacturing Plant; Shares Jump 4%	MT

Business description: Celltrion, Inc.

Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.

Number of employees: 2,391

Sales by Activity: Celltrion, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023
Bio Medical Supply	982B	1,690B	1,616B	1,937B	1,873B
Chemical Drugs	173B	242B	557B	654B	501B
Other	4.27B	2.63B	3.05B	3.88B	5.14B
Intersectoral Insider Transaction Reconciliation	-30.36B	-85.76B	-264B	-311B	-203B

See all business segments

Geographical breakdown of sales: Celltrion, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023
South Korea	1,017B	1,542B	2,015B	2,324B	2,262B
Americas	-	-	84.61B	131B	117B
Asia	-	-	76.42B	140B	-
Foreign	111B	308B	-	-	-
Consolidation Adjustment	-	-	-264B	-311B	-203B

See all geographic segments

Managers: Celltrion, Inc.

Director	Title	Age	Since
Wu-Sung Ki CEO	Chief Executive Officer	-	2015-03-19
Ho-Seop Lee DFI	Director of Finance/CFO	49	-
Sung-Han Lee CMP	Compliance Officer	42	-
Yoon-Mo Koo PRN	Corporate Officer/Principal	54	-
Sang-Joon Lee PRN	Corporate Officer/Principal	57	-

See CELLTRION, INC. governance

Members of the board: Celltrion, Inc.

Manager	Title	Age	Since
Jung-Jin Seo CHM	Chairman	67	-
Dong-Il Kim BRD	Director/Board Member	66	2008-07-16
Joseph Lee BRD	Director/Board Member	66	2008-07-16
Gyun-Seok Cho BRD	Director/Board Member	65	2009-03-19
Byung-Hoon Jeon BRD	Director/Board Member	67	2014-03-26
Jong-Seok Lee BRD	Director/Board Member	72	2014-12-07
Geun-Young Kim BRD	Director/Board Member	64	-
Dae-Hyeon Yoo BRD	Director/Board Member	66	-
Soon-Woo Lee BRD	Director/Board Member	74	-
Jae-Sik Lee BRD	Director/Board Member	66	-

Composition of the Board of Directors

Shareholders: Celltrion, Inc.

Name	Equities	%	Valuation
Jung-Jin Seo 27.66 %	60,047,570	27.66 %	8 049 M ₩
National Pension Service of Korea 6.235 %	13,534,497	6.235 %	1 814 M ₩
CELLTRION, INC. 3.054 %	6,629,434	3.054 %	889 M ₩
Temasek Holdings Pte Ltd. (Investment Management) 2.544 %	5,523,531	2.544 %	740 M ₩
Celltrion Inc. Employee Stock Ownership ASSN. 0.2472 %	536,669	0.2472 %	72 M ₩

List of CELLTRION, INC. shareholders

Holdings: Celltrion, Inc.

Name	Equities	%	Valuation
CELLTRION PHARM, INC. 54.80%	22,797,613	54.80%	924,945,211 $
CELLTRION, INC. 3.05%	6,629,434	3.05%	888,644,933 $
BIOTOXTECH CO., LTD. 10.22%	1,631,134	10.22%	3,700,619 $

Company details: Celltrion, Inc.

Celltrion, Inc.

23 Academy-ro Yeonsu-gu

22014, Inchon

+82 3 2850 5000

http://www.celltrion.com

Other Biotechnology & Medical Research

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
CELLTRION, INC.	-2.78%	-5.15%	+4.41%	-11.97%	26.11B
LONZA GROUP AG	-0.65%	-1.89%	+57.59%	-31.27%	43B
IQVIA HOLDINGS INC.	+1.88%	+2.30%	-4.11%	-23.30%	36.78B
ICON PUBLIC LIMITED COMPANY	+0.81%	+2.65%	-19.54%	-19.87%	17.95B
MODERNA, INC.	+2.72%	+3.14%	-43.16%	-83.23%	17.1B
UNITED THERAPEUTICS CORPORATION	-0.72%	-0.84%	+51.87%	+96.21%	16.5B
BIO-TECHNE CORPORATION	+3.88%	+1.82%	+13.31%	-34.16%	11.84B
MEDPACE HOLDINGS, INC.	+0.48%	+2.88%	+24.38%	+70.70%	10.87B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+5.18%	+0.25%	-1.33%	-43.50%	9.81B
QIAGEN N.V.	+2.07%	+1.53%	+2.92%	-20.77%	9.65B
Average	+1.29%	+0.28%	+8.64%	-10.11%	19.96B
Weighted average by Cap.	+0.70%	-0.11%	+13.25%	-14.87%